{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:56Z","timestamp":1786997876011,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.urology.2008.05.045","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T04:53:50Z","timestamp":1227848030000},"page":"1198-1202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Is Quantitative Histologic Examination Useful to Predict Nonorgan-Confined Prostate Cancer When Saturation Biopsy Is Performed?"],"prefix":"10.1016","volume":"72","author":[{"given":"P.","family":"Pepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fraggetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Galia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Aragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2008.05.045_bib1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"Combination of PSA, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2008.05.045_bib2","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1056\/NEJMcp0706784","article-title":"Localized prostate cancer","volume":"357","author":"Walsh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2008.05.045_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5","article-title":"Evaluation of a nomogram used to predict pathologic stage of clinically localized prostate carcinoma","volume":"79","author":"Kattan","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.05.045_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eururo.2005.06.016","article-title":"Prognostic parameters other than Gleason score for the daily evaluation of prostate cancer in needle biopsy","volume":"48","author":"Algaba","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/cncr.20415","article-title":"Prostate needle biopsies: Multiple variables are predictive of final tumor volume in radical prostatectomy","volume":"101","author":"Poulos","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.05.045_bib6","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2004.01.164","article-title":"Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favourable intermediate-risk disease","volume":"22","author":"D'Amico","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2008.05.045_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0090-4295(02)02525-6","article-title":"Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: Results from the search database","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.05.045_bib8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0022-5347(05)65077-X","article-title":"Percent of cancer in the biopsy set predicts pathological findings after prostatectomy","volume":"167","author":"Grossklaus","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.ju.0000103929.91486.29","article-title":"Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension","volume":"171","author":"Naya","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0090-4295(02)02287-2","article-title":"Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: The center for prostate disease research nomograms","volume":"61","author":"Gancarczyk","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.05.045_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1442-2042.2007.01809.x","article-title":"Percentages of positive cores, cancer length and Gleason grade 4\/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy","volume":"14","author":"Suekane","year":"2007","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejso.2004.12.002","article-title":"Prediction by quantitative histology of pathological stage in prostate cancer","volume":"31","author":"Pepe","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.urology.2008.05.045_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eururo.2006.03.026","article-title":"High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series","volume":"50","author":"Walz","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.urology.2007.05.017","article-title":"High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates","volume":"70","author":"Sajadi","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.05.045_bib15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.urology.2007.07.068","article-title":"Saturation prostate needle biopsy and prostate cancer at initial and repeat evaluation","volume":"70","author":"Pepe","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.05.045_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2004.11.007","article-title":"Incidence of prostate cancer in Sicily: Results of a multicenter case-findings protocol","volume":"47","author":"Aragona","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.5858\/2000-124-0995-PFIPC","article-title":"Prognostic factors in prostate cancer: College of American Pathologists Consensus Statement 1999","volume":"124","author":"Bostwick","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.urology.2008.05.045_bib18","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/1097-0142(20010615)91:12<2322::AID-CNCR1264>3.0.CO;2-H","article-title":"Prediction of prostate carcinoma stage by quantitative biopsy pathology","volume":"91","author":"Veltri","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.05.045_bib19","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.eururo.2006.07.042","article-title":"Prostate cancer nomograms: An update","volume":"50","author":"Felix","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib20","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1097\/01.ju.0000124463.13319.0a","article-title":"Preoperative model for predicting PSA recurrence after radical prostatectomy using percent of biopsy with cancer, biopsy Gleason grade and serum PSA","volume":"171","author":"Freedland","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0090-4295(02)01654-0","article-title":"Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy","volume":"59","author":"Nelson","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2008.05.045_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-5347(01)69076-1","article-title":"Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than PSA or Gleason score","volume":"167","author":"Freedland","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1078-1439(03)00017-6","article-title":"Contemporary preoperative parameters predict cancer-free after radical prostatectomy: A tool to facilitate treatment decisions","volume":"21","author":"Nelson","year":"2003","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2008.05.045_bib24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0022-5347(05)66933-9","article-title":"The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: Implications for treatment selection","volume":"164","author":"Gao","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00000478-200304000-00002","article-title":"Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population","volume":"27","author":"Bismar","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urology.2008.05.045_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.eururo.2006.06.051","article-title":"A pretreatment table for the prediction of final histopathology after radical prostatectomy in clinical unilateral T3a prostate cancer","volume":"51","author":"Joniau","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2008.05.045_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/cncr.11153","article-title":"Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate cancer: A multiinstitutional validation study","volume":"97","author":"Haese","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2008.05.045_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathological and clinical findings to predict tumor extent of non palpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429508007528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429508007528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:48:01Z","timestamp":1758764881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429508007528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0090429508007528"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2008.05.045","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Quantitative Histologic Examination Useful to Predict Nonorgan-Confined Prostate Cancer When Saturation Biopsy Is Performed?","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2008.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}